ตรวจข้อสอบ > กิตติพัฒน์​ สมิติษเฐียร > Medical Aptitude Test and Competition | Upper-Secondary (Grade 10 - 12) > Part 1 > ตรวจ

ใช้เวลาสอบ 3 นาที

Back

# คำถาม คำตอบ ถูก / ผิด สาเหตุ/ขยายความ ทฤษฎีหลักคิด/อ้างอิงในการตอบ คะแนนเต็ม ให้คะแนน
1


What role does the ISCT play in the context of cell and gene therapies?

It opposes the premature commercialization of unproven therapies.

ISCT wants cell and gene therapies to be carefully tested before they are sold or used on patients. It believes that new treatments should go through proper research, laboratory studies, and clinical trials to make sure they are safe and effective. ISCT speaks against clinics or companies that sell unproven therapies because these treatments may not work and could even harm patients. Its goal is to protect patients while supporting the responsible development of new medical treatments.

This answer is based on the principles of patient safety and evidence-based medicine. ISCT supports using scientific research and clinical trial evidence to ensure that cell and gene therapies are safe and effective before they are offered to patients.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

2


What is a potential consequence for patients using unproven CGT products?

Risk of serious adverse effects

Using unproven cell and gene therapy (CGT) products can be dangerous because they have not been fully tested for safety or effectiveness. Patients may experience serious side effects, unexpected health problems, or receive a treatment that does not work. They may also waste time and money while delaying proper medical care. This is why experts recommend using only treatments that have been approved after proper research and clinical trials.

This answer is based on the principles of patient safety and evidence-based medicine, which state that treatments should be scientifically tested in clinical trials to prove they are safe and effective before being used on patients.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

3


What is the primary goal of the ISCT's position on cell and gene therapies as mentioned in the article?

To support evidence-based products and oppose unproven ones

The ISCT's main goal is to make sure that cell and gene therapies are supported by strong scientific evidence before they are used in patients. The organization encourages researchers and companies to test treatments through proper clinical trials to prove they are safe and effective. At the same time, it warns against selling or using unproven therapies because they may not work and could seriously harm patients. This helps protect patients and builds public trust in cell and gene therapies.

This is based on the principle of evidence-based medicine (EBM), which states that medical treatments should only be used after being supported by reliable scientific research, clinical evidence, and safety testing. The ISCT follows this principle by promoting scientifically proven therapies and opposing unproven treatments.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

4


How do regulatory bodies like the FDA and EMA ensure the safety of CGT products?

By requiring rigorous pre-marketing clinical trials

The FDA and EMA help ensure that cell and gene therapy (CGT) products are safe by requiring companies to complete rigorous pre-marketing clinical trials before approval. These trials test whether the treatment is safe, effective, and whether the benefits outweigh the risks. Regulators carefully review all the scientific and clinical data before allowing the therapy to be used by the public. This process helps protect patients from unsafe or ineffective treatments.

This is based on the principle of evidence-based medicine (EBM) and regulatory approval, which require treatments to be supported by strong scientific evidence, clinical trial results, and safety evaluations before they can be approved for public use.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

5


Which of the following is NOT a typical characteristic of unproven CGT products as discussed in the article?

Approval by major regulatory agencies

Unproven cell and gene therapy (CGT) products are not approved by major regulatory agencies such as the FDA or EMA. Instead, they often have little scientific evidence, lack proper pre-clinical or clinical testing, and are promoted using patient testimonials rather than reliable research. These treatments can also be very expensive, even though their safety and effectiveness have not been proven. Therefore, approval by major regulatory agencies is not a characteristic of unproven CGT products.

This is based on the principles of evidence-based medicine (EBM) and regulatory approval, which require therapies to pass scientific testing and safety evaluations before they can be approved for patient use.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

6


Which of the following is a risk associated with unproven CGT products highlighted in the article?

Potential for serious health risks

The article explains that unproven cell and gene therapy (CGT) products may cause serious health risks because they have not been properly tested in clinical trials. Without enough scientific evidence, the treatments may be unsafe, ineffective, or lead to unexpected side effects. Patients may also spend large amounts of money on therapies that do not provide real medical benefits. This is why using unproven CGT products can be dangerous.

This is based on the principles of evidence-based medicine (EBM) and patient safety, which state that medical treatments should be proven safe and effective through clinical research before being used in patients.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

7


What key feature differentiates proven CGT products from unproven ones according to regulatory standards?

Pre-marketing authorization by regulatory bodies

The main difference between proven and unproven cell and gene therapy (CGT) products is that proven therapies have received pre-marketing authorization from regulatory bodies such as the FDA or EMA. Before approval, these therapies must pass strict laboratory studies and clinical trials to show they are safe, effective, and of good quality. Unproven therapies do not go through this complete approval process, so their safety and effectiveness are not confirmed.

This is based on the principles of evidence-based medicine (EBM) and regulatory approval, which require strong scientific evidence, successful clinical trials, and official review by regulatory agencies before a therapy can be approved for public use.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

8


What ethical consideration is primarily challenged by direct-to-consumer marketing of unproven cell and gene therapies?

Informed consent processes

Direct-to-consumer marketing of unproven cell and gene therapies can mislead patients by making treatments seem more effective or safer than they really are. As a result, patients may agree to receive the therapy without fully understanding the risks, lack of scientific evidence, or possible side effects. This weakens the process of informed consent, which requires patients to receive complete and accurate information before making a medical decision.

This is based on the ethical principle of informed consent and patient autonomy, which state that patients have the right to make their own healthcare decisions only after receiving clear, truthful, and complete information about the benefits, risks, and alternatives of a treatment.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

9


According to the article, which of the following is NOT a recognized reporting mechanism for adverse effects from cell and gene therapies?

Consumer Protection Agencies

The article states that adverse effects from cell and gene therapies should be reported through official medical safety reporting systems, such as MedWatch (FDA), EudraVigilance (EMA), and the TGA safety reporting portal. These systems are designed to collect and monitor reports of side effects so regulators can identify safety problems and protect patients. Consumer Protection Agencies are not official systems for reporting adverse effects from medical treatments, so they are not recognized reporting mechanisms in the article.

This answer is based on the principle of pharmacovigilance, which is the continuous monitoring of the safety of medicines and medical therapies after they are used. Regulatory agencies such as the FDA, EMA, and TGA use official adverse event reporting systems to collect safety data, investigate risks, and take action when necessary to protect public health.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

10


What term is used to describe the appearance of scientific credibility used in the marketing of unproven cell-based therapies?

Tokens of scientific legitimacy

The article uses the term "tokens of scientific legitimacy" to describe how some clinics make unproven cell-based therapies appear scientifically credible. They may display scientific-looking language, references to research, laboratory images, or doctor credentials to convince patients that the treatment is trustworthy, even though there is not enough scientific evidence or regulatory approval. This marketing strategy can mislead patients into believing the therapy has been proven safe and effective.

This answer is based on the principles of evidence-based medicine (EBM) and scientific integrity. Medical treatments should be supported by reliable research, clinical trials, and regulatory approval. Simply using scientific language or symbols of credibility ("tokens of scientific legitimacy") does not prove that a therapy is safe or effective.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

11


Which auditory feature is NOT directly studied in the newborn auditory processing research?

Language comprehension.

Newborn auditory processing research focuses on basic hearing abilities, such as beat perception, statistical learning, rhythmic entrainment, and melody recognition. These abilities help infants detect patterns and sounds before they understand words.

This answer is based on developmental neuroscience and infant auditory processing research, which show that newborns can recognize sounds, rhythms, and patterns early in life. However, understanding the meaning of spoken language (language comprehension) develops later as the brain and language skills mature.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

12


What does an isochronous condition in an auditory study typically involve?

A consistent temporal interval between sounds.

An isochronous condition means that sounds are played with equal time gaps between them, creating a steady and predictable rhythm. Researchers use this condition to study how the brain detects rhythm, timing, and patterns without changes in the spacing of sounds. It helps measure auditory processing more accurately.

This answer is based on the principle of auditory rhythm perception in cognitive neuroscience. In auditory experiments, isochronous means equal time intervals between consecutive sounds, allowing researchers to examine beat perception, rhythmic processing, and neural responses under controlled timing conditions.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

13


What is the primary purpose of using EEG in studies of auditory processing in newborns?

To record brain responses to sounds.

EEG (Electroencephalography) is used to record the electrical activity of the brain while newborns listen to sounds. It helps researchers understand how babies process speech, rhythm, and other auditory information, even though they cannot speak or respond. EEG is safe, painless, and can detect very small brain responses to sound.

This answer is based on the principle of electroencephalography (EEG) in neuroscience. EEG measures the brain's electrical signals through electrodes placed on the scalp, allowing researchers to study auditory processing and neural responses to sounds in newborns without requiring any behavioral response.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

14


How does beat perception in newborns relate to their later musical abilities?

It is fundamental for developing rhythmic coordination and timing.

Beat perception helps newborns recognize and follow a regular rhythm. This early ability supports the development of rhythmic coordination and timing, which are important for later musical skills such as moving to a beat, dancing, and playing music. However, it does not directly predict that a child will become good at playing instruments, singing, or composing music.

This answer is based on research in developmental neuroscience and music cognition, which shows that early beat perception is a foundation for rhythm processing and sensorimotor synchronization. These basic timing skills support later musical development, but they do not guarantee specific musical talents or achievements.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

15


Which neural mechanism is thought to underlie the synchronization of movement to a beat?

Neural entrainment.

Neural entrainment is the process where the brain's electrical activity synchronizes with the regular rhythm of sounds. This synchronization helps people predict the timing of the next beat, making it easier to move, clap, tap, or dance in time with music. It is considered the main neural mechanism behind movement synchronized to a beat.

This answer is based on the theory of neural entrainment in cognitive neuroscience. The theory explains that brain oscillations align with external rhythmic stimuli, supporting beat perception, timing prediction, and sensorimotor synchronization, which are essential for coordinated movement with music.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

16


Which condition in the EEG study did NOT result in a differentiation between beat and offbeat responses in newborns?

Silence condition.

In the EEG study, newborns can only show a difference between beat and offbeat responses when there is an auditory rhythm to process. In the isochronous, jittered, melodic, and harmonic conditions, there are sounds with timing or musical structure, so the newborns’ brains can detect rhythm patterns and show different EEG responses for beats and offbeats.

In the silence condition, there is no sound or rhythmic input at all. Because of this, the brain has no auditory signal to synchronize with or compare timing against, so it cannot produce any differentiation between beat and offbeat responses. This idea is based on auditory rhythm processing and neural entrainment, which requires external sound to organize brain responses to timing patterns.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

17


What does the term "statistical learning" refer to in the context of auditory processing in newborns?

Extraction of regularities from the order of sounds without explicit feedback.

In auditory processing in newborns, “statistical learning” refers to the brain’s ability to automatically pick up patterns from the sounds it hears. This means newborns can notice which sounds often occur together or in a certain order, even without being taught or given feedback. It is not about actively learning language rules, but about passively detecting patterns in the environment.

This concept is based on early cognitive neuroscience research showing that infants are sensitive to the statistical structure of auditory input. They can track how often sounds follow each other and use this information to form basic expectations about sound sequences, which is an early foundation for later language learning.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

18


What does the mismatch response (MMR) in EEG studies indicate about newborns' auditory processing?

Sensitivity to regularity violations in sound sequences.

In EEG studies, the mismatch response (MMR) appears when newborns hear a sound that breaks a pattern they have been listening to. This shows that their brain has already formed an expectation about the regular sequence of sounds, and it reacts when something is different or “does not fit” that pattern.

The MMR is based on the idea of early auditory prediction and statistical learning. It reflects the brain’s ability to automatically detect changes or violations in repetitive sound patterns without needing conscious attention or learning, showing that newborns are already sensitive to regularities in auditory input.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

19


According to the research, what experimental method is used to differentiate beat perception from statistical learning in newborns?

Monitoring brain activity using EEG during auditory stimulation.

The research uses EEG to measure newborns’ brain responses while they listen to different sound patterns. This allows scientists to see how the brain reacts to beat structure versus statistical patterns in real time. By comparing EEG responses during auditory stimulation, researchers can tell whether the brain is responding to rhythm (beat perception) or to learned sound regularities (statistical learning).

EEG (electroencephalography) is a standard method in cognitive neuroscience for studying infant auditory processing because it directly records neural activity. It helps distinguish different types of processing by showing specific brain response patterns, such as those linked to beat perception and mismatch responses for statistical learning.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

20


Which of the following best describes the concept of "beat perception" as it relates to the auditory capabilities of newborn infants?

The extraction of a consistent rhythm from a sequence of sounds.

Beat perception in newborns refers to the brain’s ability to pick out a steady, repeating timing pattern from a stream of sounds. Even when sounds vary, the brain can still organize them into a regular pulse or “beat.” This allows newborns to sense rhythm in auditory input rather than just hearing random noises.

This concept is based on research in auditory rhythm processing and neural entrainment, which shows that even early in life, the brain can align its activity with periodic sound patterns. Beat perception is specifically about detecting temporal regularity, not identifying instruments, melody, or producing sounds.

7

-.50 -.25 +.25 เต็ม 0 -35% +30% +35%

ผลคะแนน 124.05 เต็ม 140

แท๊ก หลักคิด
แท๊ก อธิบาย
แท๊ก ภาษา